Jeffrey Ubben acquired 622 Thousand Myriad Genetics shares worth $3.44 Million. That's 0.07% of their equity portfolio (13th largest holding). Jeffrey Ubben acquired their 622 Thousand shares in Q1 2010. So far they never sold any shares in the company. The investor's estimated purchase price is $14.7 Million, resulting in a loss of 77%.